Le marché du diagnostic SIBO était évalué à 138 324,23 000 USD en 2020, et il devrait atteindre 194 604,51 000 USD d'ici 2028 ; il devrait croître à un TCAC de 4,4 % de 2021 à 2028.
La prolifération bactérienne de l'intestin grêle (SIBO) est couramment observée en présence d'une ou plusieurs conditions prédisposantes. Il varie fortement en fonction des troubles sous-jacents et des caractéristiques du microbiote des patients et des organismes. Le SIBO entraîne des symptômes gastro-intestinaux de type IBS, qui pourraient être asymptomatiques. Dans les pires cas, il peut en résulter un véritable syndrome de malabsorption. La présence de SIBO est généralement diagnostiquée avec des tests respiratoires à l'hydrogène lactulose et au glucose. Ces tests sont largement pratiqués dans tous les contextes cliniques en raison de leur faible coût, de leur caractère non invasif, de leur précision et de leur reproductibilité suffisantes.
Le marché des diagnostics SIBO est segmenté en fonction du diagnostic, du type et de la géographie. Sur la base de la géographie, le marché est segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique et en Amérique du Sud et centrale. Le rapport offre des informations et une analyse approfondie du marché du diagnostic SIBO en mettant laccent sur divers paramètres tels que les tendances du marché, les progrès technologiques, la dynamique du marché et lanalyse du paysage concurrentiel des principaux acteurs du marché à travers le monde. Il comprend également une analyse d'impact du COVID-19 dans toutes les régions. On estime que le marché devrait connaître un taux de croissance plus lent au cours de la période de prévision en raison des services de santé restreints et de la situation de verrouillage causée par la pandémie de COVID-19.
Régions lucratives pour le marché des diagnostics SIBO
Aperçu du marché
Augmentation de la prévalence du syndrome du côlon irritable (IBS) et du SIBO
Le syndrome du côlon irritable (IBS) est le trouble gastro-intestinal couramment diagnostiqué avec des douleurs abdominales et des habitudes intestinales altérées entraînant des symptômes associés tels que ballonnements, malabsorption et symptômes systémiques. Les incidences du SCI augmentent à un rythme significatif à travers le monde. Selon un article de recherche, ‘Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study publié par Elsevier Inc. en 2021, la plupart des pays ont un taux de prévalence de 2 à 6%. Des pays comme le Japon, la Chine, la Russie, l'Afrique du Sud et les États-Unis ont un taux de prévalence de 2,2 %, 2,3 %, 5,9 %, 5,9 % et 5,3 %, respectivement. La prévalence croissante du SCI dans le monde est due à l'évolution du mode de vie et des habitudes alimentaires. La prolifération bactérienne de l'intestin grêle (SIBO) est largement associée au SCI.
De même, le SIBO présente des symptômes similaires au SCI. Les développements technologiques ont maintenant permis le diagnostic de SIBO tout en diagnostiquant l'IBS. Par conséquent, la prévalence de SIBO est largement comprise et signalée dans le monde entier. Par exemple, selon un article intitulé « Small Intestinal Bacterial Overgrowth : A Case-Based Review » publié dans le Journal of Patient-Centered Research and Reviews (JPCRR) en novembre 2015, 30 à 85 % des patients adultes atteints du SII sont susceptibles de développer SIBO. De même, selon les données récentes publiées en 2020 par l'American College of Gastroenterology, environ 78 % des patients atteints du SCI vivent avec le SBIO ; par conséquent, il s'agit d'une condition principalement évaluée. On estime donc que la prévalence de l'IBS et du SIBO augmentera de manière significative dans un avenir proche, entraînant une augmentation du diagnostic et une éventuelle croissance du marché.
Insights basés sur le diagnostic
Basés lors du diagnostic, le marché des diagnostics SIBO est segmenté en tests respiratoires, test d'aspiration et de culture de liquide de l'intestin grêle, test sanguin et autres. En 2020, le segment des tests respiratoires détenait la plus grande part du marché et devrait également croître au rythme le plus rapide dans les années à venir. La croissance est attribuée en raison de ses avantages, tels que non invasif, convivial pour le patient, simplicité et faible coût
Marché mondial des diagnostics SIBO, par diagnostic - 2020 et 2028
Aperçus basés sur le type
Sur la base du type, le marché du diagnostic SIBO est segmenté en SIBO à prédominance hydrogène, SIBO à prédominance méthane et SIBO récurrent. En 2020, le segment SIBO à prédominance hydrogène détenait la plus grande part du marché, et le même segment devrait croître au rythme le plus rapide au cours des années à venir.
Perspectives stratégiques
Les stratégies organiques telles que le lancement de produits sont couramment adoptées par les acteurs du marché pour répondre à l'évolution de la demande des clients et maintenir leurs services améliorés. Par exemple, en février 2020, Commonwealth Diagnostics International (CDI), Inc., a annoncé la relance commerciale d'IBSchek, le premier test sanguin de biomarqueur cliniquement validé pour le syndrome du côlon irritable à prédominance diarrhéique et de type mixte (IBS-D, IBS -M) dans un nouveau kit de prélèvement capillaire à domicile.
Par diagnostic
- Test respiratoire
- Test respiratoire au xylose 14C
- Tests respiratoires à l'hydrogène
- Test respiratoire à l'acide glycocholique 14C
- Tests de malabsorption
- Test d'aspiration et de culture de liquide de l'intestin grêle
- Test sanguin
- Autres
Par type
- SIBO à prédominance hydrogène
- Méthane- SIBO prédominant
- SIBO récurrent
Par géographie
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Asie-Pacifique (APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'APAC
- Moyen-Orient et Afrique (MEA)
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste du MEA
- Amérique du Sud et centrale (SCAM)
- Brésil
- Argentine
- Reste de SCAM
Profils d'entreprise
- Genova Diagnostics
- SIBO Diagnostics
- Commonwealth Diagnostics International
- Aerodiagnostics, LLC
- SIBOTest
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- DirectLabs, LLC
- Bien-être dynamique
- Groupe médical Health Associates
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Small intestinal bacterial growth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. The presence of SIBO is generally diagnosed with hydrogen lactulose and glucose breath tests. These tests are widely performed in every clinical setting due to their low costs, non-invasively, sufficient accuracy, and reproducibility.
Key factors that are driving growth of the market are increasing incidence of IBS and SIBO and advantages offered by breath tests. However, limitation of diagnostics is a key factor restraining the market growth.
The cost is based on the type of diagnostics test. For instance, the hydrogen breath test is much cheaper than any other test. The cost of the test ranges from US$ 145–US$ 400. Likewise, the cost of endoscopy is ~US$ 135.
The List of Companies - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
- Genova Diagnostics
- SIBO Diagnostics
- Commonwealth Diagnostics International
- Aerodiagnostics, LLC
- SIBOTest
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- DirectLabs, LLC
- Vibrant Wellness
- Health Associates Medical Group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)